Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism 5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H26N6OS |
InChIKeyUMDLGBGKSYLCIH-UHFFFAOYSA-N |
CAS Registry2410053-43-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neuropsychiatric syndrome | Preclinical | United States | 03 Jun 2025 |





